Y. Hoshino et al., Role of the cytomegalovirus (CMV)-antigenemia assay as a predictive and follow-up detection tool for CMV disease in AIDS patients, MICROB IMMU, 43(10), 1999, pp. 959-965
Forty-two patients were evaluated to determine the value of the CMV antigen
emia (CMV-Ag) test as a follow-up marker as well as a prediction marker of
CMV disease, Twenty patients were positive for at least one positive CMV-Ag
assay and 9 of them developed CMV retinitis, With the threshold value (10
positive cells), sensitivity was 56% and specificity was 94%, The CMV-Ag as
say, with the threshold value, produced high specificity, positive predicti
ve value and negative predictive value but relatively poor sensitivity, Eig
ht patients experienced CMV disease relapse a total of 16 times. At relapse
, 8 of the 16 times showed negative for CMV-Ag assay; 7 underwent systemic
maintenance while 1 underwent local maintenance. It is inferred that the CM
V-Ag test is a poor follow-up marker to detect the relapse of CMV disease,
particularly in patients undergoing systemic maintenance.